Development of a novel therapy for Huntington’s Disease
Laufzeit: 01.01.2011 - 31.12.2018
Laufzeit: 01.01.2011 - 31.12.2018
Huntington’s Disease (HD) is a devastating neurodegenerative disorder that is inherited in an autosomal dominant manner, which cannot be cured. The present project suggests to search for small chemical molecules that specifically inhibit the synthesis of disease causing protein in HD patients. These molecules are supposed to have the ability to inhibit or delay disease development and progression in gene carriers.